Literature DB >> 10670881

Bone substitutes.

F D Burstein1.   

Abstract

The search for the ideal bone substitute began hundreds of years ago, and continues today. While numerous choices have been proposed and tested, with varying degrees of success, there remain many challenges related to the use of bone substitutes in craniofacial reconstruction. This paper presents a review of the history of bone substitute research, a discussion of currently popular materials, and elucidation of the challenges to be faced as we approach the new millennium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10670881     DOI: 10.1597/1545-1569_2000_037_0001_esntit_2.3.co_2

Source DB:  PubMed          Journal:  Cleft Palate Craniofac J        ISSN: 1055-6656


  5 in total

1.  Protein and mineral composition of osteogenic extracellular matrix constructs generated with a flow perfusion bioreactor.

Authors:  Richard A Thibault; Antonios G Mikos; F Kurtis Kasper
Journal:  Biomacromolecules       Date:  2011-11-09       Impact factor: 6.988

2.  A simple critical-sized femoral defect model in mice.

Authors:  Bret H Clough; Matthew R McCarley; Carl A Gregory
Journal:  J Vis Exp       Date:  2015-03-15       Impact factor: 1.355

3.  Evaluation of a novel nanocrystalline hydroxyapatite paste Ostim in comparison to Alpha-BSM - more bone ingrowth inside the implanted material with Ostim compared to Alpha BSM.

Authors:  Franz-Xaver Huber; Nicholas McArthur; Lydia Heimann; Elvira Dingeldein; Héloïse Cavey; Xavier Palazzi; Gaëlle Clermont; Jean-Pierre Boutrand
Journal:  BMC Musculoskelet Disord       Date:  2009-12-22       Impact factor: 2.362

4.  Evaluation of a novel nanocrystalline hydroxyapatite paste and a solid hydroxyapatite ceramic for the treatment of critical size bone defects (CSD) in rabbits.

Authors:  Franz-Xaver Huber; Irina Berger; Nicholas McArthur; Colette Huber; Hans-Peter Kock; Jürgen Hillmeier; Peter Jürgen Meeder
Journal:  J Mater Sci Mater Med       Date:  2007-06-14       Impact factor: 3.896

5.  Short Term Culture of Human Mesenchymal Stem Cells with Commercial Osteoconductive Carriers Provides Unique Insights into Biocompatibility.

Authors:  Matthew B Murphy; Richard K Suzuki; Theodore T Sand; Christopher D Chaput; Carl A Gregory
Journal:  J Clin Med       Date:  2013-08-19       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.